LGGDY.PK

Legend Capital leads ForQaly Medical's Series B financing

星期五, 十月 8, 2021 - 7:13am

Recently, it completed its Series B fundraising led by Legend Capital, followed by CD Capital, SAIF Partners, Chengwei Chuangban and Co-win Ventures.

Key Points: 
  • Recently, it completed its Series B fundraising led by Legend Capital, followed by CD Capital, SAIF Partners, Chengwei Chuangban and Co-win Ventures.
  • Existing investors Lilly Asia Ventures and Kaitai Capital also participated in the funding round.
  • Joe Zhou, the Managing Director of Legend Capital, said: "VAD, especially the interventional one, has a huge market prospect in China.
  • We are glad to partner with ForQaly Medical and will establish a long-term cooperation with the company.

Legend Capital is reaping the rewards in its logistics and supply chain investment

星期一, 九月 27, 2021 - 4:46am

As a comprehensive fund covering multiple industries and fields, Legend Capital has already made a long-term and systematic investment layout in the field of logistics and supply chain.

Key Points: 
  • As a comprehensive fund covering multiple industries and fields, Legend Capital has already made a long-term and systematic investment layout in the field of logistics and supply chain.
  • Based on nearly a decade of experience, Legend Capital has already built an accomplished framework and investment system in the field of logistics and supply chain.
  • Richard Li, the President of Legend Capital, said: "Logistics and supply chain investment has entered the critical period, and there will be more cross-industry investment opportunities.
  • According to Legend Capital, the logistics and supply chain industry has entered a new stage with information technology empowers various industries.

Legend Capital Led a New Round of Investment of Etana

星期二, 九月 14, 2021 - 12:42am

HONG KONG, Sept 14, 2021 - (ACN Newswire) - Legend Capital led a new round of investment of PT Etana Biotechnologies Indonesia (Etana), along with Innovent Biologics, Inc. (Innovent) (HKEX: 01801), and a consortium led by UOB Venture Management (UOBVM).

Key Points: 
  • HONG KONG, Sept 14, 2021 - (ACN Newswire) - Legend Capital led a new round of investment of PT Etana Biotechnologies Indonesia (Etana), along with Innovent Biologics, Inc. (Innovent) (HKEX: 01801), and a consortium led by UOB Venture Management (UOBVM).
  • Hong Tan, Managing Director of Legend Capital, said "We appreciate Etana's vision to provide Indonesia with cost-effective biopharmaceuticals.
  • Legend Capital is an independent professional venture capital company under Legend Holdings.
  • Its core business is positioned at the initial stage of venture capital and expansion stage growth investment.